ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
24.81
+1.38 (5.89%)
At close: Mar 9, 2026, 4:00 PM EDT
24.81
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:02 PM EDT
ArriVent BioPharma Market Cap
ArriVent BioPharma has a market cap or net worth of $1.11 billion as of March 9, 2026. Its market cap has increased by 19.82% in one year.
Market Cap
1.11B
Enterprise Value
792.68M
1-Year Change
19.82%
Ranking
Category
Stock Price
$24.81
Market Cap Chart
Since the IPO on January 26, 2024, ArriVent BioPharma's market cap has increased from $575.22M to $1.11B, an increase of 92.26%. That is a compound annual growth rate of 36.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 1.04B | 24.69% |
| Dec 31, 2025 | 830.58M | -7.48% |
| Dec 31, 2024 | 897.69M | 56.06% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inventiva | 1.15B |
| Pharming Group | 1.06B |
| AbCellera Biologics | 1.05B |
| Inhibrx Biosciences | 1.01B |
| Xeris Biopharma Holdings | 1.00B |
| UroGen Pharma | 996.04M |
| Compass Therapeutics | 992.28M |
| GH Research | 988.13M |